Health Economic Evaluation Of Elective Cardioversion Of Atrial Fibrillation With Rivaroxaban Versus Vitamin K Oral Antagonists

Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1235
https://www.valueinhealthjournal.com/article/S1098-3015(17)31569-3/fulltext
Section Title : Disease-Specific Studies
Section Order : 1180
First Page : A616
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31569-3&doi=10.1016/j.jval.2017.08.1235
HEOR Topics :
Tags :
Regions :